GlassScriptPhysician profile
Priya B Maseelall
NPI 1699945790
$4,729.92
in general payments reported to CMS, 2019-2025
15 companies · $542 in 2025
The $542 reported for 2025 was more than what 88% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,419 · 2020: $1,424 · 2021: $337 · 2022: $276 · 2023: $382 · 2024: $350 · 2025: $542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,273.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $1,790.73 | 2019-2025 | Menopur |
| Organon LLC | $999.48 | 2021-2025 | Ganirelix Acetate, Follistim Aq, Pregnyl |
| Merck Sharp & Dohme LLC | $532.12 | 2019-2021 | |
| Abbvie INC. | $503.63 | 2019-2020 | |
| Avion Pharmaceuticals | $287.99 | 2019-2020 | |
| Coopersurgical, INC. | $242.24 | 2020-2024 | Stripper |
| Vertical Pharmaceuticals, LLC | $123.43 | 2019 | |
| Emd Serono, INC. | $108.40 | 2019 | |
| Hologic Sales and Service, LLC | $43.95 | 2019-2021 | |
| Duchesnay USA Incorporated | $25.86 | 2019 | |
| Myovant Sciences INC. | $20.74 | 2022 | |
| Therapeuticsmd, INC. | $13.71 | 2019 | |
| Minerva Surgical, INC | $13.65 | 2024 | |
| Exeltis, USA INC. | $12.36 | 2019 | |
| Meditrina | $11.63 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priya Maseelall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.